Intrahepatic Cholangiocarcinoma (Icc) Clinical Trials in Guangzhou, Guangdong
2 recruitingGuangzhou, Guangdong, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC
Intrahepatic Cholangiocarcinoma (Icc)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University38 enrolled1 locationNCT06925516
Recruiting
Phase 2
A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma
Intrahepatic Cholangiocarcinoma (Icc)
Beijing InnoCare Pharma Tech Co., Ltd.70 enrolled44 locationsNCT05678270